birb 796 has been researched along with ml 3403 in 1 studies
Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (ml 3403) | Trials (ml 3403) | Recent Studies (post-2010) (ml 3403) |
---|---|---|---|---|---|
137 | 5 | 80 | 5 | 0 | 2 |
Protein | Taxonomy | birb 796 (IC50) | ml 3403 (IC50) |
---|---|---|---|
Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.8538 | |
Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.8538 | |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.8538 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.7748 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domeyer, DM; Hauser, DR; Kinkel, K; Laufer, SA; Liedtke, AJ | 1 |
1 other study(ies) available for birb 796 and ml 3403
Article | Year |
---|---|
Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.
Topics: Drug Design; Humans; Imidazoles; Molecular Mimicry; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Structure-Activity Relationship | 2008 |